NEWS and OPINIONS

#TalkingRegMed Special: World Stem Cell Summit highlights with Adam Price-Evans

RegMedNet Interview with Bernard Siegel

In this interview, filmed exclusively at the World Stem Cell Summit (22-26 January, 2018, Miami, Florida), Bernie Siegel discusses how the Regenerative Medicine Foundation came to be set up. He also shares his thoughts for the future of regenerative medicine and in...

read more
You Saw the Grammys, But You Missed the More Important Awards

You Saw the Grammys, But You Missed the More Important Awards

The 2018 Stem Cell Action Awards, honoring recipients for advocacy, leadership, and inspiration, presented by the Regenerative Medicine Foundation. (Courtesy RMF) By: Kira Peikoff Editor-in-Chief show profile VIEW THE FULL ARTICLE HERE   Last week in Miami, more...

read more
Longeveron Alzheimer’s Disease Trial

Longeveron Alzheimer’s Disease Trial

Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem...

read more
Longeveron Aging Frailty Phase 2b Trial

Longeveron Aging Frailty Phase 2b Trial

Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only...

read more